BioDlink announced that its self-developed bevacizumab injection biosimilar has received marketing approval from Colombia’s National Institute for Surveillance of Medicines and Foods (INVIMA) and Pakistan’s Drug Regulatory Authority of Pakistan (DRAP).
Should Every ACL Get E-Stim? What the New NMES Meta-Analysis Really Shows
New meta-analysis: Early NMES after ACL surgery boosts quad strength. When and how should sports PTs use it? We break